Literature DB >> 23105020

Burkholderia multivorans survival and trafficking within macrophages.

Crystal L Schmerk1,2, Miguel A Valvano1,2.   

Abstract

Cystic fibrosis (CF) patients are at great risk of opportunistic lung infection, particularly by members of the Burkholderia cepacia complex (Bcc). This group of bacteria can cause damage to the lung tissue of infected patients and are difficult to eradicate due to their high levels of antibiotic resistance. Although the highly virulent Burkholderia cenocepacia has been the focus of virulence research for the past decade, Burkholderia multivorans is emerging as the most prevalent Bcc species infecting CF patients in North America. Despite several studies detailing the intramacrophage trafficking and survival of B. cenocepacia, no such data exist for B. multivorans. The results of this study demonstrated that the clinical CF isolates C5568 and C0514 and an environmental B. multivorans isolate, ATCC 17616, were able to replicate and survive within murine macrophages in a manner similar to that of B. cenocepacia strain K56-2. These strains were also able to survive but were unable to replicate within human THP-1 macrophages. Differences in macrophage uptake were observed among all three B. multivorans strains; these variances were attributed to major differences in O-antigen production. Unlike B. cenocepacia-containing vacuoles, which delay phagosomal maturation in murine macrophages by 6 h, all B. multivorans-containing vacuoles co-localized with lysosome-associated membrane protein-1, a late endosome/lysosomal marker, and the lysosomal marker dextran within 2 h of uptake. Together, these results indicated that, whilst both Bcc species were able to survive and replicate within macrophages, they utilized different intramacrophage survival strategies. To observe differences in virulence, the strains were compared using the Galleria mellonella (wax worm) model. When compared with the B. multivorans strains tested, B. cenocepacia K56-2 was highly virulent in this model and killed all worms within 24 h when injected at 10(7) c.f.u. B. multivorans clinical isolates C5568 and C0514 were significantly more virulent than the soil isolate ATCC 17616, which was avirulent even when worms were injected with 10(7) c.f.u. These results suggest strain differences in the virulence of B. multivorans isolates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23105020     DOI: 10.1099/jmm.0.051243-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Burkholderia cenocepacia Lipopolysaccharide Modification and Flagellin Glycosylation Affect Virulence but Not Innate Immune Recognition in Plants.

Authors:  Maryam Khodai-Kalaki; Angel Andrade; Yasmine Fathy Mohamed; Miguel A Valvano
Journal:  MBio       Date:  2015-06-04       Impact factor: 7.867

3.  Sm16, a major component of Schistosoma mansoni cercarial excretory/secretory products, prevents macrophage classical activation and delays antigen processing.

Authors:  David E Sanin; Adrian P Mountford
Journal:  Parasit Vectors       Date:  2015-01-06       Impact factor: 3.876

4.  An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity.

Authors:  Matthew M Schaefers; Tiffany L Liao; Nicole M Boisvert; Damien Roux; Deborah Yoder-Himes; Gregory P Priebe
Journal:  PLoS Pathog       Date:  2017-01-03       Impact factor: 6.823

5.  Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection.

Authors:  A Amir Hassan; Carla P Coutinho; Isabel Sá-Correia
Journal:  Front Cell Infect Microbiol       Date:  2019-07-31       Impact factor: 5.293

6.  Burkholderia cenocepacia transcriptome during the early contacts with giant plasma membrane vesicles derived from live bronchial epithelial cells.

Authors:  Andreia I Pimenta; Nuno Bernardes; Marta M Alves; Dalila Mil-Homens; Arsenio M Fialho
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

7.  Protein with negative surface charge distribution, Bnr1, shows characteristics of a DNA-mimic protein and may be involved in the adaptation of Burkholderia cenocepacia.

Authors:  Ruth Dennehy; Niamh Duggan; Simon Dignam; Sarah McCormack; Eugene Dillon; Jessica Molony; Maria Romano; Yueran Hou; Laura Ardill; Matthew V X Whelan; Zuzanna Drulis-Kawa; Tadhg Ó'Cróinín; Miguel A Valvano; Rita Berisio; Siobhán McClean
Journal:  Microbiologyopen       Date:  2022-02       Impact factor: 3.904

Review 8.  Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.

Authors:  Paul J Planet
Journal:  J Pediatric Infect Dis Soc       Date:  2022-09-07       Impact factor: 5.235

9.  Burkholderia multivorans: A rare yet emerging cause of bacterial meningitis.

Authors:  Diego P Peralta; Aymara Y Chang; Angie Ariza-Hutchinson; Catherine A Ho
Journal:  IDCases       Date:  2018-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.